Company / Revenue per Share
BIOMERICA INC Revenue per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.32
FY2024
5-year range
$0.32 / $1.61
FY2020-FY2024
Trend
-25.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share has declined for 3 consecutive years, from $1.61 in FY2021 to $0.32 in FY2024.
Based on SEC 10-K filings.
0.32 in FY2024 with a 5-year CAGR of -11.6%.
Declined from $0.43 to $0.32 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -41.9%
- 5-Year CAGR
- -11.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- BIOMERICA INC's revenue per share has declined for 3 consecutive years.
- In FY2024, revenue per share decreased 25.0% year-over-year.
- Peak revenue per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -6.26 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0.32 | -25.0% |
| FY2023 | $0.42 | -3.0% |
| FY2022 | $0.43 | -73.0% |
| FY2021 | $1.61 | +116.1% |
| FY2020 | $0.74 | +27.1% |
| FY2019 | $0.59 | -4.2% |
| FY2018 | $0.61 | -10.3% |
| FY2017 | $0.68 | -11.0% |
| FY2016 | $0.77 | +12.3% |
As of FY2024 · SEC Form 10-K · Last checked Jun 22, 2026